Sonic Healthcare (SHL) Profit Report - FY15 result in line with July 2015 earnings update
Sonic Healthcare's organic revenue growth was ~5%, enhanced by accretive acquisitions. Australian Laboratory revenue growth of 5% included 0.5% relating to the SAN Pathology acquisition was completed in December 2014. Fees and volumes were negatively impacted by Medicare changes from 1 November 2014. Net operating cashflow was down 8% to $512m. Read our full summary here: (VIEW LINK)
1 stock mentioned
Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.